Does pathological complete response after neoadjuvant chemoradiotherapy associate with long-term survival in esophageal cancer: A systematic review and meta-analysis

7Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This meta-analysis examines the impact of pathological complete response (pCR) on long-term survival in locally advanced esophageal cancer patients treated with neoadjuvant chemoradiotherapy (NCRT) and surgery. A systematic review of 38 studies found that pCR correlates with improved overall survival (HR = 0.54) and disease-free survival (HR = 0.51). The findings suggest that pCR may serve as a surrogate endpoint for evaluating the survival outcomes of NCRT.

Cite

CITATION STYLE

APA

Sun, J., Sun, C., Zhang, Y., Jin, Z., Witharana, T., Li, J., … Shen, J. (2025, December 1). Does pathological complete response after neoadjuvant chemoradiotherapy associate with long-term survival in esophageal cancer: A systematic review and meta-analysis. BMC Surgery. BioMed Central Ltd. https://doi.org/10.1186/s12893-025-03016-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free